(2026). Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein. EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Correction: Combined Antitumor Activity of [177Lu]Lu-FAPI-2286 and Pazopanib in a Sarcoma Model: A Preclinical Theranostic Study Targeting Fibroblast Activation Protein."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Correction: Combined Antitumor Activity of [177Lu]Lu-FAPI-2286 and Pazopanib in a Sarcoma Model: A Preclinical Theranostic Study Targeting Fibroblast Activation Protein."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.